McCarthy Sean A.insider trades
In SEC Form 4 filings, McCarthy Sean A. is listed as CEO of CytomX Therapeutics, Inc. (CTMX). McCarthy Sean A. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CTMXCytomX Therapeutics, Inc. | CEO | 3 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
Dashed line = amended filing (Form 4/A)
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CTMXCytomX Therapeutics, Inc. | Nov 6, 2025 | Oct 164/A | M | 101,793 | $1.59 | $161,851 | 1,191,477 | Yes | Form 4/A |
| CTMXCytomX Therapeutics, Inc. | Nov 6, 2025 | Oct 164/A | S | 101,793 | $4.54 | Sale −$461,906 | 1,089,684 | Yes | Form 4/A |
| CTMXCytomX Therapeutics, Inc. | Nov 6, 2025 | Oct 164/A | M · derivative | 101,793 | $1.59 | $161,851 | 348,207 | Yes | Form 4/A |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.